Total planned funding: $674,870,084
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $674,870,084 |
Organizational Types
NGO | $178,128,789 |
Private Contractor | $141,938,868 |
Host Country Government Agency | $94,292,781 |
Own Agency | $93,288,978 |
Unknown | $76,473,593 |
University | $54,246,521 |
Parastatal | $12,455,544 |
Implementing Agency | $9,841,995 |
Other USG Agency | $5,657,574 |
FBO | $5,301,683 |
Multi-lateral Agency | $3,243,758 |
Program Areas
Treatment | $182,824,748 |
Prevention | $145,276,259 |
Care | $134,851,359 |
Governance and Systems | $98,858,801 |
Management and Operations | $67,051,506 |
Testing | $46,007,411 |
Budget Codes
HTXS: Treatment: Adult Treatment | $152,035,348 |
HVMS: Management and Operations | $67,051,506 |
HKID: Care: Orphans and Vulnerable Children | $56,013,643 |
OHSS: Health Systems Strengthening | $46,193,464 |
HVCT: Testing: HIV Testing and Counseling | $46,007,411 |
HVOP: Sexual Prevention: Other Sexual Prevention | $43,683,644 |
HBHC: Care: Adult Care and Support | $42,070,086 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $40,195,918 |
HVSI: Strategic Information | $39,956,036 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $27,660,191 |
HVTB: Care: TB/HIV | $24,505,655 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $22,709,326 |
HTXD: Treatment: ARV Drugs | $15,824,923 |
PDTX: Treatment: Pediatric Treatment | $14,964,477 |
HLAB: Laboratory Infrastructure | $12,709,301 |
PDCS: Care: Pediatric Care and Support | $12,261,975 |
HMBL: Biomedical Prevention: Blood Safety | $6,194,118 |
HMIN: Biomedical Prevention: Injection Safety | $4,833,062 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$84,331,999
Countries/Regions
Not Available:
$60,989,358
Countries/Regions
USG Aggregated Agencies:
$56,634,294
Countries/Regions